2024-08-012025-07-312025-07-31false08162494PGK MEDICAL LIMITED2026-01-0568100falseiso4217:GBPxbrli:pure081624942024-07-31081624942025-07-31081624942024-08-012025-07-31081624942023-07-31081624942024-07-31081624942023-08-012024-07-3108162494bus:SmallEntities2024-08-012025-07-3108162494bus:AuditExempt-NoAccountantsReport2024-08-012025-07-3108162494bus:FullAccounts2024-08-012025-07-3108162494bus:PrivateLimitedCompanyLtd2024-08-012025-07-3108162494core:WithinOneYear2025-07-3108162494core:AfterOneYear2025-07-3108162494core:WithinOneYear2024-07-3108162494core:AfterOneYear2024-07-3108162494core:ShareCapital2025-07-3108162494core:SharePremium2025-07-3108162494core:RevaluationReserve2025-07-3108162494core:OtherReservesSubtotal2025-07-3108162494core:RetainedEarningsAccumulatedLosses2025-07-3108162494core:ShareCapital2024-07-3108162494core:SharePremium2024-07-3108162494core:RevaluationReserve2024-07-3108162494core:OtherReservesSubtotal2024-07-3108162494core:RetainedEarningsAccumulatedLosses2024-07-3108162494core:LandBuildings2025-07-3108162494core:PlantMachinery2025-07-3108162494core:Vehicles2025-07-3108162494core:FurnitureFittings2025-07-3108162494core:OfficeEquipment2025-07-3108162494core:NetGoodwill2025-07-3108162494core:IntangibleAssetsOtherThanGoodwill2025-07-3108162494core:ListedExchangeTraded2025-07-3108162494core:UnlistedNon-exchangeTraded2025-07-3108162494core:LandBuildings2024-07-3108162494core:PlantMachinery2024-07-3108162494core:Vehicles2024-07-3108162494core:FurnitureFittings2024-07-3108162494core:OfficeEquipment2024-07-3108162494core:NetGoodwill2024-07-3108162494core:IntangibleAssetsOtherThanGoodwill2024-07-3108162494core:ListedExchangeTraded2024-07-3108162494core:UnlistedNon-exchangeTraded2024-07-3108162494core:LandBuildings2024-08-012025-07-3108162494core:PlantMachinery2024-08-012025-07-3108162494core:Vehicles2024-08-012025-07-3108162494core:FurnitureFittings2024-08-012025-07-3108162494core:OfficeEquipment2024-08-012025-07-3108162494core:NetGoodwill2024-08-012025-07-3108162494core:IntangibleAssetsOtherThanGoodwill2024-08-012025-07-3108162494core:ListedExchangeTraded2024-08-012025-07-3108162494core:UnlistedNon-exchangeTraded2024-08-012025-07-3108162494core:MoreThanFiveYears2024-08-012025-07-3108162494core:Non-currentFinancialInstruments2025-07-3108162494core:Non-currentFinancialInstruments2024-07-3108162494dpl:CostSales2024-08-012025-07-3108162494dpl:DistributionCosts2024-08-012025-07-3108162494core:LandBuildings2024-08-012025-07-3108162494core:PlantMachinery2024-08-012025-07-3108162494core:Vehicles2024-08-012025-07-3108162494core:FurnitureFittings2024-08-012025-07-3108162494core:OfficeEquipment2024-08-012025-07-3108162494dpl:AdministrativeExpenses2024-08-012025-07-3108162494core:NetGoodwill2024-08-012025-07-3108162494core:IntangibleAssetsOtherThanGoodwill2024-08-012025-07-3108162494dpl:GroupUndertakings2024-08-012025-07-3108162494dpl:ParticipatingInterests2024-08-012025-07-3108162494dpl:GroupUndertakingscore:ListedExchangeTraded2024-08-012025-07-3108162494core:ListedExchangeTraded2024-08-012025-07-3108162494dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-08-012025-07-3108162494core:UnlistedNon-exchangeTraded2024-08-012025-07-3108162494dpl:CostSales2023-08-012024-07-3108162494dpl:DistributionCosts2023-08-012024-07-3108162494core:LandBuildings2023-08-012024-07-3108162494core:PlantMachinery2023-08-012024-07-3108162494core:Vehicles2023-08-012024-07-3108162494core:FurnitureFittings2023-08-012024-07-3108162494core:OfficeEquipment2023-08-012024-07-3108162494dpl:AdministrativeExpenses2023-08-012024-07-3108162494core:NetGoodwill2023-08-012024-07-3108162494core:IntangibleAssetsOtherThanGoodwill2023-08-012024-07-3108162494dpl:GroupUndertakings2023-08-012024-07-3108162494dpl:ParticipatingInterests2023-08-012024-07-3108162494dpl:GroupUndertakingscore:ListedExchangeTraded2023-08-012024-07-3108162494core:ListedExchangeTraded2023-08-012024-07-3108162494dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-08-012024-07-3108162494core:UnlistedNon-exchangeTraded2023-08-012024-07-3108162494core:NetGoodwill2025-07-3108162494core:IntangibleAssetsOtherThanGoodwill2025-07-3108162494core:LandBuildings2025-07-3108162494core:PlantMachinery2025-07-3108162494core:Vehicles2025-07-3108162494core:FurnitureFittings2025-07-3108162494core:OfficeEquipment2025-07-3108162494core:AfterOneYear2025-07-3108162494core:WithinOneYear2025-07-3108162494core:ListedExchangeTraded2025-07-3108162494core:UnlistedNon-exchangeTraded2025-07-3108162494core:ShareCapital2025-07-3108162494core:SharePremium2025-07-3108162494core:RevaluationReserve2025-07-3108162494core:OtherReservesSubtotal2025-07-3108162494core:RetainedEarningsAccumulatedLosses2025-07-3108162494core:NetGoodwill2024-07-3108162494core:IntangibleAssetsOtherThanGoodwill2024-07-3108162494core:LandBuildings2024-07-3108162494core:PlantMachinery2024-07-3108162494core:Vehicles2024-07-3108162494core:FurnitureFittings2024-07-3108162494core:OfficeEquipment2024-07-3108162494core:AfterOneYear2024-07-3108162494core:WithinOneYear2024-07-3108162494core:ListedExchangeTraded2024-07-3108162494core:UnlistedNon-exchangeTraded2024-07-3108162494core:ShareCapital2024-07-3108162494core:SharePremium2024-07-3108162494core:RevaluationReserve2024-07-3108162494core:OtherReservesSubtotal2024-07-3108162494core:RetainedEarningsAccumulatedLosses2024-07-3108162494core:NetGoodwill2023-07-3108162494core:IntangibleAssetsOtherThanGoodwill2023-07-3108162494core:LandBuildings2023-07-3108162494core:PlantMachinery2023-07-3108162494core:Vehicles2023-07-3108162494core:FurnitureFittings2023-07-3108162494core:OfficeEquipment2023-07-3108162494core:AfterOneYear2023-07-3108162494core:WithinOneYear2023-07-3108162494core:ListedExchangeTraded2023-07-3108162494core:UnlistedNon-exchangeTraded2023-07-3108162494core:ShareCapital2023-07-3108162494core:SharePremium2023-07-3108162494core:RevaluationReserve2023-07-3108162494core:OtherReservesSubtotal2023-07-3108162494core:RetainedEarningsAccumulatedLosses2023-07-3108162494core:AfterOneYear2024-08-012025-07-3108162494core:WithinOneYear2024-08-012025-07-3108162494core:Non-currentFinancialInstrumentscore:CostValuation2024-08-012025-07-3108162494core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-08-012025-07-3108162494core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-08-012025-07-3108162494core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-08-012025-07-3108162494core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-08-012025-07-3108162494core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-08-012025-07-3108162494core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-08-012025-07-3108162494core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-08-012025-07-3108162494core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-08-012025-07-3108162494core:Non-currentFinancialInstrumentscore:CostValuation2025-07-3108162494core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-07-3108162494core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-07-3108162494core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-07-3108162494core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-07-3108162494core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-07-3108162494core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-07-3108162494core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-07-3108162494core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-07-3108162494core:Non-currentFinancialInstrumentscore:CostValuation2024-07-3108162494core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-07-3108162494core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-07-3108162494core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-07-3108162494core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-07-3108162494core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-07-3108162494core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-07-3108162494core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-07-3108162494core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-07-3108162494bus:Director12024-08-012025-07-3108162494bus:Director22024-08-012025-07-3108162494core:FurnitureFittingsToolsEquipment2024-07-3108162494core:FurnitureFittingsToolsEquipment2024-08-012025-07-3108162494core:FurnitureFittingsToolsEquipment2025-07-31

PGK MEDICAL LIMITED

Registered Number
08162494
(England and Wales)

Unaudited Financial Statements for the Year ended
31 July 2025

PGK MEDICAL LIMITED
Company Information
for the year from 1 August 2024 to 31 July 2025

Directors

KOUMELLIS, Panayiotis, Dr
LEKANIDI, Aikaterini, Dr

Registered Address

10 Sydney Road
Haywards Heath
RH16 1PZ

Registered Number

08162494 (England and Wales)
PGK MEDICAL LIMITED
Statement of Financial Position
31 July 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets31,069,6451,092,563
1,069,6451,092,563
Current assets
Debtors7,9068,614
Cash at bank and on hand15,39414,873
23,30023,487
Creditors amounts falling due within one year4(88,038)(86,503)
Net current assets (liabilities)(64,738)(63,016)
Total assets less current liabilities1,004,9071,029,547
Creditors amounts falling due after one year5(394,248)(526,146)
Net assets610,659503,401
Capital and reserves
Called up share capital100100
Profit and loss account610,559503,301
Shareholders' funds610,659503,401
The financial statements were approved and authorised for issue by the Board of Directors on 5 January 2026, and are signed on its behalf by:
KOUMELLIS, Panayiotis, Dr
Director
Registered Company No. 08162494
PGK MEDICAL LIMITED
Notes to the Financial Statements
for the year ended 31 July 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Basis of preparation
The financial statements have been prepared under the historical cost convention on a going concern basis unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and/or the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to the Income Statement
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. The assets residual values, useful lives and depreciation methods are reviewed and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date. Gains and losses on disposal are determined by comparing the proceeds with the carrying amount and are recognised in the Income Statement Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)Straight line (years)
Land and buildings-50
Fixtures and fittings25-
Office Equipment33-
2.Average number of employees

20252024
Average number of employees during the year22
3.Tangible fixed assets

Land & buildings

Fixtures & fittings

Office Equipment

Total

££££
Cost or valuation
At 01 August 241,144,1496,98314,6241,165,756
Additions--2,7472,747
At 31 July 251,144,1496,98317,3711,168,503
Depreciation and impairment
At 01 August 2459,5273,36810,29873,193
Charge for year22,8839041,87825,665
At 31 July 2582,4104,27212,17698,858
Net book value
At 31 July 251,061,7392,7115,1951,069,645
At 31 July 241,084,6223,6154,3261,092,563
4.Creditors: amounts due within one year

2025

2024

££
Bank borrowings and overdrafts40,92950,600
Taxation and social security42,19327,080
Other creditors2,6776,748
Accrued liabilities and deferred income2,2392,075
Total88,03886,503
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
5.Creditors: amounts due after one year

2025

2024

££
Bank borrowings and overdrafts394,248526,146
Total394,248526,146
The directors have provided a personal guarantee against bank borrowings totalling £435,177.